The Enterprise Value as of December 2025 (TTM) for Enorama Pharma AB (publ) (ERMA.ST) is 144.11M

According to Enorama Pharma AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 144.11M. This represents a change of -14.45% compared to the average of 168.44M of the last 4 quarters.

Enorama Pharma AB (publ) (ERMA.ST) Historical Enterprise Value (quarterly & annually)

How has ERMA.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Enorama Pharma AB (publ) over the last ten years is 152.13M. The current 144.11M Enterprise Value has changed 9.37% with respect to the historical average. Over the past ten years (40 quarters), ERMA.ST's Enterprise Value was at its highest in in the March 2018 quarter at 443.69M. The Enterprise Value was at its lowest in in the June 2016 quarter at 12.40M.

Enorama Pharma AB (publ) (ERMA.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Enorama Pharma AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enorama Pharma AB (publ) (ERMA.ST) Average Enterprise Value

How has ERMA.ST Enterprise Value performed in the past?

The current Enterprise Value of Enorama Pharma AB (publ) (ERMA.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Enorama Pharma AB (publ) (ERMA.ST) Enterprise Value vs. Peers

How is ERMA.ST’s Enterprise Value compared to its peers?

Enorama Pharma AB (publ)’s Enterprise Value is less than Klaria Pharma Holding AB (publ.) (175.87M), greater than Isofol Medical AB (publ) (140.80M), greater than Annexin Pharmaceuticals AB (publ) (108.54M), greater than AcuCort AB (103.31M), less than Clinical Laserthermia Systems AB (publ) (171.55M), less than SenzaGen AB (157.53M), greater than Vivesto AB (68.86M), less than iZafe Group AB (publ) (163.20M), less than Integrum AB (publ) (242.64M), less than AlzeCure Pharma AB (publ) (196.46M),

Build a custom stock screener for Enorama Pharma AB (publ) (ERMA.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enorama Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enorama Pharma AB (publ) (ERMA.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enorama Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.